My Size (MYSZ) Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for My Size in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MYSZ shares.
View MYSZ analyst ratings or view top-rated stocks.

1 brokerages have issued 1-year target prices for My Size's stock. Their MYSZ share price forecasts range from $3.00 to $3.00. On average, they anticipate the company's share price to reach $3.00 in the next year. This suggests a possible upside of 247.2% from the stock's current price.
View analysts price targets for MYSZ or view top-rated stocks among Wall Street analysts.

My Size's stock was trading at $2.72 at the beginning of 2023. Since then, MYSZ stock has decreased by 68.2% and is now trading at $0.8641.
View the best growth stocks for 2023 here.

My Size saw a decrease in short interest during the month of September. As of September 15th, there was short interest totaling 26,200 shares, a decrease of 74.5% from the August 31st total of 102,700 shares. Based on an average daily trading volume, of 179,700 shares, the short-interest ratio is currently 0.1 days. Approximately 1.3% of the company's stock are short sold.
View My Size's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 21st 2023.
View our MYSZ earnings forecast.

My Size, Inc. (NASDAQ:MYSZ) released its earnings results on Monday, August, 14th. The company reported ($1.80) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.41) by $0.39. The business earned $2.01 million during the quarter, compared to the consensus estimate of $2.50 million. My Size had a negative trailing twelve-month return on equity of 235.73% and a negative net margin of 170.35%.

My Size shares reverse split before market open on Friday, December 9th 2022. The 1-25 reverse split was announced on Friday, December 9th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, December 9th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other My Size investors own include Cemtrex (CETX), Aethlon Medical (AEMD), Citius Pharmaceuticals (CTXR), Inpixon (INPX), Avinger (AVGR), Aytu BioPharma (AYTU), Fujian Blue Hat Interactive Entertainment Technology (BHAT), Blink Charging (BLNK), Check-Cap (CHEK) and iBio (IBIO).

My Size trades on the NASDAQ under the ticker symbol "MYSZ."

Shares of MYSZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MYSZ stock can currently be purchased for approximately $0.86.

My Size (NASDAQ:MYSZ) has a market capitalization of $2.11 million and generates $4.46 million in revenue each year.

My Size's mailing address is HAYARDEN 4 POB 1026, AIRPORT CITY L3, 7010000. The official website for the company is www.mysizeid.com. The company can be reached via phone at (723) 600-9030 or via email at ir@mysizeid.com.